Escribano, Baby Boy .
HRN: 25-38-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/29/2024
07/06/2024
IV
27mg
Q24hours
T/c Neonatal Pneumonia
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes